Background
Decades of empirical research have fundamentally reshaped our understanding of placebo effects. Scientific interest has shifted from the nature of the placebo agent itself to the active psychological and neurobiological mechanisms through which it simulates and modulates therapeutic efficacy. Placebo effects are not mere artifacts of research design: they involve complex processes that are engaged whenever a patient receives a treatment, whether inert or pharmacologically active. Their negative counterpart, the nocebo effect, refers to adverse events arising from negative expectations and beliefs, which can worsen clinical outcomes and reduce the effectiveness of therapies.
Key factors shaping placebo and nocebo responses include patient expectations, prior learning, and individual needs, as well as the clinical and environmental setting and the quality of the doctor-patient relationship. Understanding and harnessing these mechanisms is therefore not only a scientific priority but also a clinical and educational one.
Despite the growing body of evidence, knowledge of placebo and nocebo effects remains largely confined to specialist research contexts and rarely reaches healthcare students, practitioners, or the general public. This gap calls for dedicated educational efforts. The projects hosted on this platform, PANACEA and ECHOO, were designed precisely to address this need: to translate scientific knowledge into accessible, effective educational resources for healthcare students and professionals, and health consumers across Europe.
Overall Goals (Education on Placebo)
ECHOO Goals
PANACEA Goals
PANACEA is addressed at various target groups, both within and outside the partner institutions:
ECHOO broadens this scope, addressing all health consumers across two interconnected communities: